Care Access Research - Hoboken

Hoboken, New Jersey 07030

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling